Cosmo Pharmaceuticals N.V. (FRA:C43)
Germany
· Delayed Price · Currency is EUR 98.50
+5.00 (5.35%)
At close: Dec 5, 2025
Cosmo Pharmaceuticals Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,555 | 1,089 | 879 | 1,015 | 1,065 | 1,136 | Upgrade
|
| Market Cap Growth | 44.91% | 23.93% | -13.36% | -4.76% | -6.21% | 10.07% | Upgrade
|
| Enterprise Value | 1,438 | 961 | 838 | 974 | 1,028 | 1,067 | Upgrade
|
| Last Close Price | 98.50 | 65.15 | 51.15 | 56.96 | 55.88 | 69.40 | Upgrade
|
| PE Ratio | 25.92 | 8.18 | - | 58.91 | 49.16 | - | Upgrade
|
| PS Ratio | 8.53 | 4.08 | 9.48 | 9.94 | 16.37 | 18.64 | Upgrade
|
| PB Ratio | 3.33 | 2.16 | 2.18 | 2.19 | 2.08 | 2.84 | Upgrade
|
| P/TBV Ratio | 14.52 | 3.48 | 3.43 | 14.09 | 9.52 | 2.87 | Upgrade
|
| P/FCF Ratio | 22.95 | 6.90 | 45.41 | 35.34 | 149.55 | 128.14 | Upgrade
|
| P/OCF Ratio | 21.16 | 6.71 | 38.72 | 30.54 | 84.48 | 87.48 | Upgrade
|
| EV/Sales Ratio | 7.91 | 3.60 | 9.03 | 9.54 | 15.80 | 17.50 | Upgrade
|
| EV/EBITDA Ratio | 17.78 | 5.99 | 90.38 | 23.65 | 57.74 | 176.12 | Upgrade
|
| EV/EBIT Ratio | 20.99 | 6.46 | - | 34.71 | 92.64 | 590.89 | Upgrade
|
| EV/FCF Ratio | 21.23 | 6.09 | 43.26 | 33.92 | 144.35 | 120.31 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.37 | 0.33 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.01 | 0.18 | 4.14 | 9.20 | 24.49 | Upgrade
|
| Debt / FCF Ratio | 0.04 | 0.01 | 0.10 | 6.05 | 23.85 | 18.97 | Upgrade
|
| Asset Turnover | 0.29 | 0.46 | 0.14 | 0.13 | 0.09 | 0.10 | Upgrade
|
| Inventory Turnover | 3.64 | 3.27 | 3.06 | 3.29 | 3.50 | 4.66 | Upgrade
|
| Quick Ratio | 3.59 | 3.39 | 3.22 | 1.45 | 11.77 | 11.06 | Upgrade
|
| Current Ratio | 3.84 | 4.19 | 4.07 | 1.57 | 12.99 | 11.60 | Upgrade
|
| Return on Equity (ROE) | 12.34% | 29.31% | -2.47% | 3.58% | 4.75% | -1.99% | Upgrade
|
| Return on Assets (ROA) | 6.88% | 15.87% | -0.18% | 2.24% | 0.99% | 0.19% | Upgrade
|
| Return on Capital (ROIC) | 8.80% | 20.39% | -0.22% | 2.66% | 1.11% | 0.20% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.20% | 24.90% | -0.40% | 5.00% | 1.40% | 0.30% | Upgrade
|
| Earnings Yield | 3.86% | 12.23% | -1.23% | 1.70% | 2.03% | -0.70% | Upgrade
|
| FCF Yield | 4.36% | 14.49% | 2.20% | 2.83% | 0.67% | 0.78% | Upgrade
|
| Dividend Yield | 2.95% | 3.15% | 3.91% | 1.84% | 1.70% | - | Upgrade
|
| Payout Ratio | 94.36% | 24.09% | - | 90.61% | - | - | Upgrade
|
| Buyback Yield / Dilution | -1.65% | -1.94% | 1.95% | 2.83% | -16.81% | 1.11% | Upgrade
|
| Total Shareholder Return | 1.30% | 1.21% | 5.86% | 4.67% | -15.11% | 1.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.